Surgical Outcomes, Quality of Life and Patient's Satisfactions With Phalloplasty
PHALLO
Surgical and Functional Outcomes, Quality of Life and Patient's Satisfactions Who Have Undergone a Phalloplasty Surgery
1 other identifier
observational
143
1 country
1
Brief Summary
The phalloplasty is a reconstruction technique, consisting of the neophallus creation. It is performed in transgender patients in sex reassignment surgery, or in cismale patients to correct a congenital or acquired lack of penis. There are many surgical techniques, but none is optimal. Surgical and functional outcomes, quality of life and patient's satisfactions with phalloplasty are missing in the international literature. Urological center of Lyon is a reference center of this kind of surgery and has the possibility to evaluate that. In this study, 124 transgender and 19 cismale patients with phalloplasty are eligible. This study will allow us to adapt our practice to the patient's return and improve the information given to patients before their surgery. It will also improve our surgical techniques, depending on the results achieved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2020
CompletedFirst Posted
Study publicly available on registry
March 19, 2020
CompletedStudy Start
First participant enrolled
May 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 14, 2020
CompletedSeptember 4, 2025
August 1, 2025
6 months
January 2, 2020
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of Sexual quality of life of patients with phalloplasty (SEAR questionnaire) from the pre-surgery (Baseline) to one year or more after surgery
Sexual quality of life is evaluated with the SEAR (self esteem and relationship questionnaire), noted in 100. It explores different fields of sexual life (sexual report, confidence, self esteem, general relationship with the partner).
One year or more after surgery (baseline)
Study Arms (2)
Transgender patients
Transgender patients who carry out sex reassignment surgery.
Cismale patients
Cismale patients who carry out surgery to correct a congenital or acquired lack of penis.
Interventions
Send a questionnaire to patients to collect informations about: * Sexual quality of life before and after the surgery * Satisfaction after surgery Data collection in medical file : * Surgery outcomes * Functional outcomes
Eligibility Criteria
Patients who have undergone a phalloplasty surgery in the University Lyon Sud Hospital or Croix Rousse Hospital, between 1 January 2007 and 31 October 2018, with at least one year of back on their surgery procedures. Patients concerned with this surgery are : * transgender patients whose reassignment surgery was validated by a minimum of three members of GRETTIS, including a psychiatrist. * Patients cis males with congenital malformations, or having suffered a total or partial amputation of verge
You may qualify if:
- Major patients
- Patients who have undergone a phalloplasty surgery in the University Lyon Sud Hospital or Croix Rousse Hospital, between 1 January 2007 and 31 October 2018
- Patients with at least one year of back on their surgery procedures
- Transgender patients whose reassignment surgery was validated by a minimum of three members of GRETTIS (Groupe de Recherche, d'Etude et de Traitement des Troubles de l'Identité Sexuelle), including a psychiatrist Or Patients cis males with congenital malformations, or having suffered a total or partial amputation of verge
- Patients who do not oppose orally to participate in the study, after information
- Patients who have given their consent for the audio recording for patients taking part in semi - directive interviews
You may not qualify if:
- Minor patients or patients under legal protection
- Refusal to participate in the study
- No understanding of the French language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Urology Department, Hospices Civis de Lyon
Pierre-Bénite, France
Related Publications (2)
Paganelli L, Morel-Journel N, Carnicelli D, Ruffion A, Boucher F, Maucort-Boulch D, Paparel P, Terrier M, Neuville P. Determining the outcomes of urethral construction in phalloplasty. BJU Int. 2023 Mar;131(3):357-366. doi: 10.1111/bju.15915. Epub 2022 Oct 26.
PMID: 36221955BACKGROUNDPelette R, Morel-Journel N, Carnicelli D, Ruffion A, Paganelli L, Vacheron CH, Terrier M, Madec FX, Neuville P. Functional outcomes after supra-pubic phalloplasty. J Plast Reconstr Aesthet Surg. 2024 Dec;99:263-270. doi: 10.1016/j.bjps.2024.09.065. Epub 2024 Sep 20.
PMID: 39393169DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2020
First Posted
March 19, 2020
Study Start
May 15, 2020
Primary Completion
November 14, 2020
Study Completion
November 14, 2020
Last Updated
September 4, 2025
Record last verified: 2025-08